(Q44292423)

English

To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Alzheimer's disease

0 references

mild cognitive impairment

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Breno Satler Diniz

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Wagner Farid Gattaz

5

object named as

Wagner Farid Gattaz

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Jony Arrais Pinto

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Maria Luiza Cavichioli Gonzaga

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Fabiana Meira Guimarães

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Orestes Vicente Forlenza

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

17 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

European Archives of Psychiatry and Clinical Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

259

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

248-256

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-0864-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-0864-1

21 January 2018

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-0864-1

21 January 2018

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-0864-1

21 January 2018

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-0864-1

21 January 2018

Do cholinergic therapies have disease-modifying effects in Alzheimer's disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The GSK3 hypothesis of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification criteria for mild cognitive impairment: a population-based validation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mild cognitive impairment: a concept ready to move on?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stability of the preclinical episodic memory deficit in Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Forecasting the global burden of Alzheimer’s disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease-modifying therapies for Alzheimer disease: challenges to early intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MCI treatment trials: failure or not?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An estimate of the total worldwide societal costs of dementia in 2005

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of galantamine in subjects with mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinergic enhancement of frontal lobe activity in mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endpoints for trials in Alzheimer's disease: a European task force consensus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19224111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00406-008-0864-1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44292423&oldid=2206548060"